{"entity":{"id":"arcsa-ecuador","kind":"institution","name":"Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA)","aka":["ARCSA","National Agency for Health Regulation, Control and Surveillance"],"tldr":"Ecuador's medicines regulator. It grants the registro sanitario a medicine needs to be sold, with a shortened route for medicines already registered by strict foreign regulators, and in 2025 began a WHO maturity level 3 pre-assessment with PAHO.","summary":"ARCSA, headquartered at Parque Samanes in Guayaquil, grants the registro sanitario (marketing authorisation) for medicines on behalf of the national health authority. Its procedure for foreign-made medicines by homologation defines homologation as the official recognition of registrations granted by countries whose regulators ARCSA lists as high health-surveillance agencies, and of medicines prequalified by WHO; the route is open only to medicines on the current Cuadro Nacional de Medicamentos Básicos, and the certificate lasts five years. The fee listed on gob.ec is 2,258.41 dollars for a foreign medicine, 565.21 for a foreign generic and 452.17 for a generic on the national list. The coordinates are approximate.\n\nPAHO wrote in October 2024 that ARCSA had begun a process to be certified under WHO's Global Benchmarking Tool as a maturity level 3 authority, and in May 2025 that it had started the pre-assessment, accompanied by PAHO and WHO staff. On 31 August 2026 the Ministry of Public Health announced a 7.4 million dollar project to renew ARCSA's vehicles and equipment for its reference laboratories in Quito, Guayaquil and Cuenca, with the aim of certification as a regional reference regulator by PAHO and WHO. The Ley Orgánica para la Atención Integral del Cáncer of March 2026 provides, according to legal summaries, a conditional registration for medicines for serious disease where the benefit outweighs the risk on preliminary evidence.","asOf":"2026-11-11","links":[{"label":"gob.ec: ARCSA, registration of foreign-made medicines by homologation","url":"https://www.gob.ec/arcsa/tramites/inscripcion-certificado-registro-sanitario-medicamentos-fabricacion-extranjera-homologacion"},{"label":"PAHO: ARCSA moves towards level III certification (14 May 2025)","url":"https://www.paho.org/es/noticias/14-5-2025-agencia-regulacion-control-vigilancia-sanitaria-va-hacia-certificacion-nivel-iii"},{"label":"PAHO: PAHO Ecuador recognised for its technical support to ARCSA (28 October 2024)","url":"https://www.paho.org/es/noticias/28-10-2024-ops-ecuador-recibio-reconocimiento-por-apoyo-compromiso-tecnico-con-agencia"},{"label":"Ministerio de Salud Pública: 7.4 million dollar investment in ARCSA (31 August 2026)","url":"https://www.salud.gob.ec/gobierno-del-presidente-noboa-ejecuta-inversion-historica-de-usd-7-4-millones-para-el-fortalecimiento-operativo-y-tecnologico-de-arcsa-hacia-estandares-de-la-ops-oms/"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["msp-ecuador","who"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Guayaquil","country":"EC","lat":-2.1,"lng":-79.9,"institutionType":"government","website":"https://www.controlsanitario.gob.ec","programs":["Registro sanitario for medicines","Registration by homologation (recognition of high-surveillance regulators and WHO prequalification)","Pharmacovigilance and post-market control","Reference laboratories in Quito, Guayaquil and Cuenca"]},"route":"/institutions/arcsa-ecuador/","neighbours":{"institution":[{"id":"msp-ecuador","kind":"institution","name":"Ministerio de Salud Pública del Ecuador","route":"/institutions/msp-ecuador/"},{"id":"who","kind":"institution","name":"World Health Organization Cancer Programme","route":"/institutions/who/"}]}}